|
TADA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93169999995746E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.54809999994588E-07 |
| Normal-vs-Stage2 |
6.847700E-04 |
| Normal-vs-Stage3 |
1.021880E-04 |
| Normal-vs-Stage4 |
1.025850E-04 |
| Stage1-vs-Stage2 |
8.433400E-01 |
| Stage1-vs-Stage3 |
5.978200E-01 |
| Stage1-vs-Stage4 |
8.198200E-01 |
| Stage2-vs-Stage3 |
8.639800E-01 |
| Stage2-vs-Stage4 |
7.375600E-01 |
| Stage3-vs-Stage4 |
5.726800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46720000038236E-07 |
| Normal-vs-AfricanAmerican |
3.687600E-02 |
| Normal-vs-Asian |
1.240470E-03 |
| Caucasian-vs-AfricanAmerican |
2.186400E-01 |
| Caucasian-vs-Asian |
4.560200E-01 |
| AfricanAmerican-vs-Asian |
5.348200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93037999999257E-05 |
| Normal-vs-Female |
3.07700000035105E-07 |
| Male-vs-Female |
9.886800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.95249999957304E-07 |
| Normal-vs-Age(41-60Yrs) |
1.5094999999965E-05 |
| Normal-vs-Age(61-80Yrs) |
1.790430E-04 |
| Normal-vs-Age(81-100Yrs) |
3.463900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.468000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.943200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.659000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.804200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.397000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.160400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.464400E-01 |
| Classical-VS-Follicular |
5.558100E-02 |
| Classical-VS-Other |
5.417600E-01 |
| Classical-VS-Normal |
2.08199999999215E-05 |
| Tall-VS-Follicular |
6.576400E-01 |
| Tall-VS-Other |
8.220400E-01 |
| Tall-VS-Normal |
4.016800E-04 |
| Follicular-VS-Other |
9.731200E-01 |
| Follicular-VS-Normal |
4.35200000004077E-06 |
| Other-VS-Normal |
5.064200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80080000022897E-07 |
| Normal-vs-N1 |
1.97443999999658E-05 |
| N0-vs-N1 |
6.418000E-01 |
|
|
